Investing Profile

Arjun Goyal

InvestorVC
Co-Founder & Managing Director at Vida Ventures
vidaventures.com/vida-team/Boston, Massachusetts
Photo of Arjun Goyal, Managing Director at Vida Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Vida Ventures Managing Director
$100K - $10.0M
$1M
10
$536.7M
CompanyStageDateRound SizeTotal Raised
Alterome Therapeutics
Series BApr 2024$130M
Series AJan 2022$64M
$230M
Co-investors: Carl Gordon (OrbiMed), Thilo Schroeder (Nextech Invest)
Quanta Therapeutics
Series DMay 2023$51M
Series COct 2021$60M
$110M
Co-investors: Maha Katabi (Sofinnova Investments)
Affini-T Therapeutics
Series UnknownMar 2022$180M
$180M
Centessa Pharmaceuticals
Series AFeb 2021$250M
$250M
Co-investors: Brett Zbar (Foresite Capital)
Scorpion Therapeutics
Series BJan 2021$160M
Series AOct 2020$110M
$270M
Co-investors: Paulina Hill (Polaris Partners), Jean-François Formela (Atlas Venture)
Allogene Therapeutics
Series AApr 2018$410M
$410M
Co-investors: Arie Belldegrun (Vida Ventures), Stefan Vitorovic (Vida Ventures)
Pionyr Immunotherapeutics
Series BDec 2017$62M
$79M
Co-investors: Carol Gallagher (New Enterprise Associates (NEA)), Leon Chen (The Column Group), Michael Powell (Omega Funds), Jack Kenney (SV Health Investors)